Dermatological Drugs Market Size Worth $34.9 Billion By 2028

Dermatological Drugs Industry Overview

The global dermatological drugs market size was valued at USD 17.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2022 to 2028. 

The key factors driving the global dermatological drug market are parasites, fungus, and other microorganisms living on the skin; bacteria trapped in skin pores and hair follicles; holding in various fluids; preventing dehydration, and increasing pollution levels. Moreover, growing awareness of skin diseases and increasing demand for rapid diagnosis, are also contributing to the growth of the dermatological drugs market. Increasing demand for innovative drugs & growing R&D investments in developing new drugs will contribute to the market revenue.

Gather more insights about the market drivers, restrains and growth of the Global Dermatological Drugs Market

During the COVID-19 pandemic and lockdown situation, the governments of various countries restricted physical movement, and citizens preferred to stay at home as a precautionary measure. Supply chains of oncology drugs were disturbed. Considering the urgency and emergency of dermatological drugs, the supply of drugs is allowed to become normal. Thus, a negligible impact of the pandemic is observed on the market revenue.

Dermatology is a branch of medical science that deals with the diagnosis, prevention, and treatment of various skin-related diseases, including hairs and nails. Dermatological drugs involve drugs that are used to treat skin diseases. The goal of dermatological drugs is to prevent skin disorders. Skin treatment includes laser therapy, topical & systemic medications, photodynamic therapy, radiotherapy, vitiligo surgery, and dermatological surgery. These dermatological drugs are also used for skincare to maintain skin features such as glow and healthiness.

This target market is expected to grow rapidly during the forecast period, owing to the increasing geriatric population, rising awareness of skin problems, soaring people's spending power, and huge reserves of dermatology drugs. In addition, the increasing prevalence of skin diseases is one of the biggest factors driving the growth of the dermatology drug market. Stress, eating habits, environmental and genetic factors, and aging are the most important factors contributing to the development of skin diseases in millions of people worldwide. According to the data published by the World Health Organization, skin diseases are one of the most common forms of health disorders, affecting nearly 900 million people worldwide at one time.

Despite efforts to manage dermatological skin conditions, there is a higher demand for the development of low-cost and therapeutically effective medicines. The growing prevalence of acne infections, atopic dermatitis (eczema), and other diseases in the population has prompted pharmaceutical companies to produce drugs for skin diseases. Companies are increasing their spending on research and development activities. For instance, in 2020, Alembic Pharmaceuticals' received FDA approval for topical retinoid “Adapalene Gel USP 0.3%” for acne vulgaris in patients ages 12 years and older.

The initiatives by governments and private organizations to develop the pharmaceutical industry are driving the growth of the market. Furthermore, the increasing number of approvals for dermatology products is propelling the growth of the market. However, the presence of acne treatment alternatives such as light or laser therapy, chemical peels, micro-needling, microdermabrasion, and lesion removal is expected to restrain the growth of the dermatology market during the forecast period.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

  • Topical Drugs Market - The global topical drugs market size was valued at USD 97.42 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2030. The industry growth is primarily driven by the rising incidence of skin disorders and diabetes. According to the British Journal of Dermatology, skin diseases affect almost one-third of the global population.
  • Dermatology Devices Market - The global dermatology devices market size was valued at over USD 12.5 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.9% over the forecast period. The increasing prevalence of skin cancer and other skin diseases is contributing largely to the high product demand.

Dermatological Drugs Market Segmentation

Grand View Research has segmented the global dermatological drugs market based on Indication and region:

Dermatological Drugs Indication Outlook (Revenue, USD Million, 2017 - 2028)

  • Acne
  • Psoriasis
  • Rosacea
  • Alopecia
  • Others

Dermatological Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Central & South America
  • Middle East & Africa

Market Share Insights

  • December 2021: Pharmaceutical company AbbVie Inc. announced that the U.S. Food and Drug Administration (FDA) approved Rinvoq (upadacitinib) for the treatment of patients with active psoriatic arthritis.

Key Companies profiled:

Some prominent players in the global dermatological drugs market include

  • Novartis AG
  • Amgen Inc
  • AbbVie Inc
  • Johnson & Johnson
  • Leo Pharma A/S
  • Eli Lilly And Company
  • GlaxoSmithKline Plc
  • AstraZeneca plc
  • Pfizer Inc
  • Merck KGaA

Order a free sample PDF of the Dermatological Drugs Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Food and Beverage ERP Solutions Procurement Intelligence: Food and Beverage ERP Solutions category is expected to have pricing growth outlook of 8.2% From 2023 To 2030

  Food and Beverage ERP Solutions Category Overview The food and beverage ERP solutions category is expected to grow at a CAGR of 8.2% from 2023 to 2030.Consumers are increasingly seeking transparency and traceability in the food and beverage business, which is fuelling this category's growth. ERP solutions can help businesses to track the origin of their ingredients and products, which can in turn help ensure food safety and meet consumer demand. The supply chain for the food and beverage industry is complex and has a wide range of players. ERP solutions can help businesses to optimize their supply chains, improve efficiency, and reduce costs. Technologies such as cloud computing, barcode scanning, and RFID labels are used under this category. Cloud computing offers a cost-effective and scalable solution for hosting ERP software, enabling remote access to data and applications. Barcode scanning is a fast and efficient method for tracking inventory and materials, improving traceabi...
Read more

Contact Center Software Market Worth $149.58 Billion By 2030

Contact Center Software Industry Overview The global contact center software market size was valued at USD 23.94 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 23.2% from 2022 to 2030.  The growth of the market can be attributed to the growing adoption of cloud-based and virtual contact center solutions to achieve better business continuity. Contact centers across the globe are focusing on transforming customer experience from a single interaction to an entire journey of consistent and personalized interactions. At this juncture, contact center software is helping businesses in ensuring a seamless customer experience across all communication channels. The strong emphasis businesses are putting on streamlining and personalizing customer interactions to enhance customer satisfaction is driving the growth of the market. According to a study by Salesforce.com, Inc., around 84% of customers consider the experience provided by a particular company e...
Read more

Manned Guarding Services Procurement Intelligence : Manned Guarding Services Category Is Expected to Grow at CAGR of 13.5% From 2024 to 2030

  Manned Guarding Services Category Overview The manned guarding services category is anticipated to witness growth at a CAGR of 13.5% from 2024 to 2030. Asia Pacific dominates the global category, followed by North America (with the fastest growth rate) and Europe. Rising standards of living, urbanization, and population are the key factors driving Asia Pacific’s growth. In addition, the region’s expanding tourism industry, coupled with political and economic stability, is also propelling the category’s expansion. The growing usage of technologies, such as access control systems and CCTV, is propelling the demand for the services offered in the category in North America. It has also helped companies to cut expenses while improving the safety of their employees and facilities. The demand in Europe is driven by the demand for more security at public events and venues and the growing incidence of terrorist incidents. Order your copy of the  Manned Guarding Services Pro...
Read more